Healthcare Sector Analytics

Market size, company revenue, drug approvals, clinical trials, regulation, hospitals, doctors, drug spending, labs and devices

Brand drug

Adalimumab-Fkjp(Cf)(Adalimumab-Fkjp)

Medicare prescription drug cost, prescriptions and prescribers, 2024

$32K

Medicare cost, 2024

Medicare drug plans spent $31,959 on Adalimumab-Fkjp(Cf) (adalimumab-fkjp) in 2024, for 30 prescriptions and refills.

Medicare cost, 2024

$32K

Prescriptions

30

$1,065.29 per claim

Patients

-

5 prescribers

Total spending, 2024

$32K

- per patient

Questions and answers

How much does Medicare spend on Adalimumab-Fkjp(Cf)?

Medicare prescription drug plans paid $32K for Adalimumab-Fkjp(Cf) in 2024, for 30 prescriptions and refills to - patients. The average cost per claim was $1,065.29.

Which state spends the most on Adalimumab-Fkjp(Cf)?

Pennsylvania had the highest Medicare cost for Adalimumab-Fkjp(Cf) in 2024: $14K for 14 claims, followed by Arkansas ($12K).

Who prescribes Adalimumab-Fkjp(Cf) the most?

Dawn M Eldred, nurse practitioner in Seneca, PA, had the highest Medicare cost for Adalimumab-Fkjp(Cf) in 2024: 13 claims costing $14K.

Spending over the years

Medicare spending by year

All plans and makers

Prescriber data: cost by year

By state

Where the prescribers practice, 2024

Medicare cost by state

States with the highest cost

Top prescribers of Adalimumab-Fkjp(Cf), 2024

By Medicare drug cost

PrescriberTypeClaimsPatientsCost
Dawn M Eldred Seneca, PANurse Practitioner13Under 11$14K
Sheri D Martin Jonesboro, ARNurse Practitioner12Under 11$12K

Prescriber data by year

YearPrescribersClaimsPatientsCost
2024530-$32K

Makers, 2024

Spending by manufacturer as listed in the spending data

ManufacturerClaimsSpending
Mylan Spec/BiocVTRS logoVTRS18$19K
Biocon BiologicBIOCON.NS logoBIOCON.NS12$13K

More drugs: Medicare drug spending and the Prescriptions view.

Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.

LinkedInLinkedInXXYouTubeYouTube